Jiangsu Yahong Meditech Co., Ltd. (SHA:688176)

China · Delayed Price · Currency is CNY

10.88

-0.33 (-2.94%)

Nov 13, 2026, 3:00 PM CST

Market Cap	6.16B +11.5%
Revenue (ttm)	319.67M +14.6%
Net Income	-529.18M
EPS	-0.94
Shares Out	566.08M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	5,557,103
Open	11.17
Previous Close	11.21
Day's Range	10.86 - 11.27
52-Week Range	8.93 - 18.11
Beta	0.39
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 28, 2026

About Jiangsu Yahong Meditech

Jiangsu Yahong Meditech Co., Ltd., a pharmaceutical company, focuses on urogenital tumors and women's health in China and internationally. It develops APL-1702, a photodynamic drug-device combination product for the treatment of high-grade squamous intraepithelial lesions of the cervix and for HPV viral clearance; APL-2302, an oral small-molecule inhibitor of the deubiquitinating enzyme ubiquitin-specific protease 1 (USP1) for the treatment of ovarian and breast cancer; APL-2501 for the treatment of ovarian cancer; AT-018 for the treatment of b... [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 2010

Employees 555

Stock Exchange Shanghai Stock Exchange

Ticker Symbol 688176

Full Company Profile

Financial Performance

In 2025, Jiangsu Yahong Meditech's revenue was 277.12 million, an increase of 37.49% compared to the previous year's 201.56 million. Losses were -416.38 million, 8.41% more than in 2024.

Financial Statements